Compositions and Methods for Treating Hemoglobinopathies
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2020/018193, filed Feb 13, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,142,760 | Compositions and Methods for Treating Hemoglobinopathies In force · Medium confidence UsedRemaining | Beam Therapeutics, Inc. | In force | Medium confidence | ||
| US 11,344,609 | Compositions and Methods for Treating Hemoglobinopathies In force · Medium confidence | Beam Therapeutics, Inc. | In force | Medium confidence | ||
| US 11,752,202 | Compositions and Methods for Treating Hemoglobinopathies In force · Low confidence | Beam Therapeutics Inc. | In force | Low confidence | ||
| US 12,016,908 | Compositions and Methods for Treating Hemoglobinopathies In force · Low confidence | Beam Therapeutics Inc. | In force | Low confidence | ||
| US 12,797,447 | Compositions and Methods for Treating Hemoglobinopathies In force · Medium confidence | Beam Therapeutics Inc. | In force | Medium confidence | ||
| Application 17/430,298 | Compositions and Methods for Treating Hemoglobinopathies Pending Not granted | Beam Therapeutics Inc. | Pending | Not granted | ||
| Application 19/372,908 | Compositions and Methods for Treating Hemoglobinopathies Pending Not granted | Beam Therapeutics Inc. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Beam Therapeutics Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.